BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1461565)

  • 1. Activation of D1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats.
    Aceves J; Floran B; Martinez-Fong D; Benitez J; Sierra A; Flores G
    Neurosci Lett; 1992 Sep; 145(1):40-2. PubMed ID: 1461565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata.
    Garcia M; Floran B; Arias-Montaño JA; Young JM; Aceves J
    Neuroscience; 1997 Sep; 80(1):241-9. PubMed ID: 9252235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat.
    Florán B; Barajas C; Florán L; Erlij D; Aceves J
    Neuroscience; 2002; 115(3):743-51. PubMed ID: 12435413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration.
    Weick BG; Engber TM; Susel Z; Chase TN; Walters JR
    Brain Res; 1990 Jul; 523(1):16-22. PubMed ID: 2119854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-1 receptor mediated modulation of the release of gamma-aminobutyric acid by endogenous dopamine in the basal ganglia of the rat.
    Aceves J; Floran B; Sierra A; Mariscal S
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Sep; 19(5):727-39. PubMed ID: 8539416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.
    Floran B; Aceves J; Sierra A; Martinez-Fong D
    Neurosci Lett; 1990 Aug; 116(1-2):136-40. PubMed ID: 2147981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study.
    Rosales MG; Martinez-Fong D; Morales R; Nuñez A; Flores G; Góngora-Alfaro JL; Flóran B; Aceves J
    Neuroscience; 1997 Oct; 80(3):803-10. PubMed ID: 9276495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dopamine D1-mediated turning behavior and striatal c-fos expression by the substantia nigra.
    Fenu S; Carta A; Morelli M
    Synapse; 1995 Apr; 19(4):233-40. PubMed ID: 7792718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa stimulates the release of [3H]gamma-aminobutyric acid in the basal ganglia of 6-hydroxydopamine lesioned rats.
    Aceves J; Floran B; Martinez-Fong D; Sierra A; Hernandez S; Mariscal S
    Neurosci Lett; 1991 Jan; 121(1-2):223-6. PubMed ID: 1902287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
    Sun BC; Zhang XX; Jin GZ
    Life Sci; 1996; 59(4):299-306. PubMed ID: 8761001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
    Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
    Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D4 and D1 dopamine receptors modulate [3H] GABA release in the substantia nigra pars reticulata of the rat.
    Acosta-García J; Hernández-Chan N; Paz-Bermúdez F; Sierra A; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2009 Dec; 57(7-8):725-30. PubMed ID: 19715708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.